Neovacs

4 Decision Makers · 4 Verified Contacts

📍 Paris, Ile-de-France, FranceBiotechnology🗓 Est. 1993👥 11–50 employees

About Neovacs

Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.

Email Deliverability

↻ Sign in to regenerate

DNS health check for neovacs.fr

Loading…

Leadership & Decision Makers

Contact details of 4 Neovacs decision makers

Miguel Sieler

Chief Executive Officer
No contact data available

Vincent Serra

Chief Scientific Officer
No contact data available

Daniel Zagury

Founder
No contact data available

Charlène Masson

Corporate Communication Director
No contact data available

General Emails

General company emails, e.g. customer support lines

contact@neovacs.com General Inquiries
info@neovacs.fr General Inquiries
bernardfanget@neovacs.fr
geraldinevogel@neovacs.fr

Similar Companies like Neovacs

Cullinan Oncology

cullinanoncology.com
Pharmaceuticals · Cambridge, MA · Est. 2017 · 11–50 employees Why similar: shared segment: Biotechnology, Medical Devices · same size band

HQ: Cambridge, MA

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees Why similar: shared segment: Therapeutics, Biotechnology

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees Why similar: shared segment: Therapeutics, Biotechnology

HQ: Lebanon, New Hampshire, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees Why similar: shared segment: Therapeutics, Biotechnology

HQ: New York, NY

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B Why similar: shared segment: Therapeutics, Biotechnology

HQ: Bothell, Washington, United States

Explore similar firms in the Biotechnology sector
Company Info
Paris, Ile-de-France, France
Specialization Therapeutics,
Business Type Public
Employees 11-50
Rounds Post-IPO Debt
Founded Date 1993
Number of Exits 1
Company Type For Profit
Stock Symbol EPA:ALNEV
Operating Status Active
Last Funding Type Post-IPO Debt
Phone Number 33 1 53 10 93 00
Last Investment Activity Jun 17, 2024
Investments Activity Jun 17, 2024May 27, 2024Jan 17, 2024
Where this data comes from

Records are compiled from publicly available sources and checked as described in our methodology.

See full email addresses & phone numbers Create a free account — no credit card needed, beta access open.

Frequently Asked Questions about Neovacs

What does Neovacs do?

Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.

Where is Neovacs headquartered?

Neovacs is headquartered in Paris, Ile-de-France, France.

When was Neovacs founded?

Neovacs was founded in 1993.

How many employees does Neovacs have?

Neovacs has approximately 11-50 employees.

What industry is Neovacs in?

Neovacs operates in the Biotechnology industry.

How do I contact Neovacs?

You can contact Neovacs via email at contact@neovacs.com or info@neovacs.fr, headquartered in Paris, Ile-de-France, France.

Explore more
Biotechnology companies Companies in Paris, Ile-de-France, France Email format guide: Biotechnology All industries Check neovacs.fr emails Request removal of a contact